Catalyst Wire Dossier Catalyst Wire Dossier

Finotonlimab

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Finotonlimab, covering 2025-06-06 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC [Phase 3]

See pricing